Orange Book product · Generic (ANDA)
MINOCYCLINE HYDROCHLORIDE
MINOCYCLINE HYDROCHLORIDE
At a glance
Sep 28, 2016
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 28, 2016
9 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
MINOCYCLINE HYDROCHLORIDE
Strength
EQ 45MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 204453
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MINOCYCLINE HYDROCHLORIDE
- 2024EMROSIBrand (NDA)
NDA 219015 · JOURNEY
- 2020ZILXIBrand (NDA)
NDA 213690 · JOURNEY
- 2019AMZEEQBrand (NDA)
NDA 212379 · JOURNEY
- 2017MINOLIRABrand (NDA)
NDA 209269 · EPI HLTH
- 2012XIMINOBrand (NDA)
NDA 201922 · JOURNEY
- 2006SOLODYNBrand (NDA)
NDA 050808 · BAUSCH
- 2001ARESTINBrand (NDA)
NDA 050781 · ORAPHARMA
- 1990MINOCINBrand (NDA)
NDA 050649 · BAUSCH
- 1982MINOCYCLINE HYDROCHLORIDEBrand (NDA)
NDA 050451 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050315 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050444 · REMPEX
- —MINOCINBrand (NDA)
NDA 050445 · BAUSCH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
